Novavax (NVAX.US) "cuts off its arm to save its life": $200M sale of Czech plant to Novo Nordisk (NVO.US)
Wednesday, Dec 4, 2024 7:10 am ET
1min read Novavax NVAX.US has agreed to sell its manufacturing facility in the Czech Republic to Novo Nordisk NVO.US for $200 million, the companies said in a statement on Wednesday.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
